Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Diaset, used alone, is meant to be taken alongside diet and exercise to help control blood sugar in people with Type II diabetes whose high blood sugar isn't adequately managed by diet alone. It can also be combined with a sulfonylurea if diet plus Diaset alone, or diet plus a sulfonylurea alone, isn't giving enough blood sugar control.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Miglitol is derived from desoxynojirimycin. It does not increase insulin secretion. Its blood-sugar-lowering effect comes from reversibly blocking the membrane-bound alpha-glucoside hydrolase enzymes found in the intestine. These enzymes normally break down oligosaccharides and disaccharides into glucose and other simple sugars at the brush border of the small intestine. By inhibiting them, Miglitol delays glucose absorption in diabetic patients and reduces the rise in blood sugar that occurs after meals. Because it lowers plasma glucose in this way, Miglitol also reduces levels of glycosylated hemoglobin.

Pregnancy & Breastfeeding

Miglitol falls under pregnancy category B. Its safety in pregnant women has not been firmly established, and because there are no adequate, well-controlled studies to confirm this, it should only be used during pregnancy if clearly necessary. Miglitol does pass into human breast milk, though only in very small amounts. Even at these low levels, nursing mothers are advised not to take Miglitol.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: There is no fixed dosage regimen for the management of diabetes mellitus with Miglitol or any other pharmacologic agent. The dosage of Miglitol must be individualized on the basis of both effectiveness and tolerance.Initial Dosage: The recommended starting dosage of Miglitol is 25 mg, given orally three times daily at the start of each main meal. However, some patients may benefit by starting at 25 mg once daily to minimize gastrointestinal adverse effects, and gradually increasing the frequency of administration to 3 times daily.Maintenance Dosage: The usual maintenance dose of Miglitol is 50 mg 3 times daily, although some patients may benefit from increasing the dose to 100 mg 3 times daily. In order to allow adaptation to potential gastrointestinal adverse effects, it is recommended that Miglitol therapy be initiated at a dosage of 25 mg 3 times daily, the lowest effective dosage, and then gradually titrated upward to allow adaptation. After 4 - 8 weeks of the 25 mg 3 times daily regimen, the dosage should be increased to 50 mg 3 times daily for approximately three months, following which a glycosylated hemoglobin level should be measured to assess therapeutic response. If, at that time, the glycosylated hemoglobin level is not satisfactory, the dosage may be further increased to 100 mg 3 times daily, the maximum recommended dosage. If no further reduction in postprandial glucose or glycosylated hemoglobin levels is observed with titration to 100 mg 3 times daily, consideration should be given to lowering the dose. Once an effective and tolerated dosage is established, it should be maintained.Maximum Dosage: The maximum recommended dosage of Miglitol is 100 mg 3 times daily.Children: The safety and effectiveness of Miglitol in pediatric patients have not been established.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.